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BK channels and 
ROMK
The kidney regulates potassium (K) 
homeostasis by both absorption and 
secretion of the filtered ion. Two K 
channels are known to exist in the distal 
nephron, the ROMK channel and the 
BK channel, the latter being calcium 
activated. Both of these channels are 
present in the collecting tubule, where K 
secretion occurs in response to increases 
in urine ﬂow rate. As they report in this 
issue, Rieg et al. studied the contribution 
of each of these channels to K secretion. 
Mice with deletion of the BK channel 
had no increase in the rate of K excre-
tion as urine ﬂow rate increased, whereas 
wild-type mice exhibited the expected 
eﬀect. Interestingly, changing K in the 
diet resulted in equivalent K excretion 
in both wild-type mice and mutant mice 
lacking the BK channel. However, ani-
mals lacking the BK channel had higher 
aldosterone levels. These animals had 
greater expression of the ROMK chan-
nel. These studies demonstrate that the 
BK channel is critical for ﬂow-induced 
K secretion, but that the ROMK channel 
can compensate for its absence. Thus, K 
homeostasis is maintained in the mutant 
mice by increased plasma aldosterone 
and upregulated ROMK. See page 566.
Endochondral bone in 
arterial calcification
Arterial calcification is emerging as 
one of the major problems in end-stage 
renal disease. Studies of its mecha-
nism show the type of calcium mineral 
formed, and the cause: it is largely due 
to specific cells located in the media 
of the arteries. These findings indi-
cated that arterial calciﬁcation might 
resemble bone formation, suggesting 
that some vascular cells could convert 
to bone-like cells. Neven et al. tested 
this hypothesis by inducing a variety 
of cell markers using the arteries of rats 
with chronic renal failure and human 
transplant donors. Remarkably, the rats 
with chronic kidney failure expressed 
markers of chondrocytes as well as spe-
ciﬁc proteins secreted by chondrocytes 
in calcifying tissues. The more severe 
the calciﬁcation, more similar was the 
matrix surrounding the calciﬁed tissues 
to that of typical chondrocytes. Human 
aorta specimens showing mild to mod-
erate media calciﬁcation also showed 
expression of chondrocyte markers. 
These studies raise the interesting 
question of whether the aortic smooth 
muscle is capable of diﬀerentiating into 
a chondrocyte-like cell, which could 
cause calciﬁcation. See page 574.
Iron sucrose versus 
ferric gluconate
One component of the anemia of 
chronic renal failure is iron deﬁciency. 
Intravenous iron is often used to treat 
the condition. Recently, many clinicians 
have replaced iron dextran with iron 
sucrose or gluconate, because sucrose or 
gluconate has lower short-term toxicity. 
However, studies in animals have sug-
gested that these two agents, especially 
iron sucrose, might be nephrotoxic. In 
a new paper, Agarwal et al. studied 12 
patients with advanced chronic kidney 
disease. The patients were randomized 
to receive the same dose of either drug 
1 week apart. Patients had signiﬁcantly 
more proteinuria after receiving iron 
sucrose than after receiving ferric glu-
conate. Proteinuria increased within 
15 minutes of the infusion. Other mark-
ers of proximal tubular toxicity, such 
as the urine N-acetyl-β-d-glucosami-
nidase/creatinine ratio, were the same 
after patients received iron sucrose and 
ferric gluconate. See page 638.
